|
May 10
|
We Think Neurizon Therapeutics (ASX:NUZ) Needs To Drive Business Growth Carefully
|
|
Nov 19
|
Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study
|
|
Oct 15
|
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics
|